HIA
EW icon

Harbor Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Harbor Investment Advisory’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
20,516
-1
-0% -$84 0.13% 128
2026
Q1 		$1.64M Sell
20,517
-203
-1% -$16.7K 0.13% 133
2025
Q4 		$1.77M Sell
20,720
-882
-4% -$72.4K 0.13% 119
2025
Q3 		$1.68M Sell
21,602
-738
-3% -$57.7K 0.14% 121
2025
Q2 		$1.75M Sell
22,340
-167
-0.7% -$12.5K 0.16% 111
2025
Q1 		$1.63M Buy
22,507
+4,682
+26% +$335K 0.16% 108
2024
Q4 		$1.32M Buy
17,825
+1,442
+9% +$101K 0.12% 126
2024
Q3 		$1.08M Buy
16,383
+2,339
+17% +$170K 0.11% 148
2024
Q2 		$1.3M Buy
14,044
+19
+0.1% +$1.68K 0.14% 118
2024
Q1 		$1.34M Buy
14,025
+396
+3% +$33.3K 0.14% 116
2023
Q4 		$1.04M Buy
13,629
+3,080
+29% +$214K 0.12% 135
2023
Q3 		$731K Buy
10,549
+1,518
+17% +$122K 0.1% 161
2023
Q2 		$852K Buy
9,031
+1,531
+20% +$133K 0.12% 156
2023
Q1 		$620K Buy
7,500
+597
+9% +$46.9K 0.09% 175
2022
Q4 		$515K Buy
6,903
+125
+2% +$9.63K 0.08% 200
2022
Q3 		$560K Buy
6,778
+232
+4% +$22.3K 0.09% 182
2022
Q2 		$622K Buy
6,546
+72
+1% +$7.45K 0.1% 173
2022
Q1 		$762K Buy
6,474
+8
+0.1% +$897 0.1% 167
2021
Q4 		$838K Sell
6,466
-2,358
-27% -$275K 0.11% 159
2021
Q3 		$999K Buy
8,824
+67
+0.8% +$7.65K 0.14% 129
2021
Q2 		$907K Buy
8,757
+20
+0.2% +$1.89K 0.12% 143
2021
Q1 		$731K Buy
8,737
+15
+0.2% +$1.27K 0.11% 156
2020
Q4 		$796K Buy
8,722
+114
+1% +$9.46K 0.13% 137
2020
Q3 		$687K Sell
8,608
-1,829
-18% -$143K 0.13% 132
2020
Q2 		$721K Sell
10,437
-4,914
-32% -$349K 0.15% 117
2020
Q1 		$965K Buy
15,351
+2,067
+16% +$149K 0.26% 87
2019
Q4 		$1.03M Buy
+13,284
New +$1.04M 0.24% 95

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Harbor Investment Advisory's EW Position: Q2 2026 in Review

Harbor Investment Advisory reduced its Edwards Lifesciences (EW) stake by 0% in Q2 2026, selling an estimated $84 and leaving 20,516 shares worth $1.86M. The position accounts for 0.13% of the portfolio, ranked #128.

Harbor Investment Advisory first reported a position in EW in Q4 2019 and has held it in 27 quarters since. 392 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Harbor Investment Advisory held 20,516 shares of Edwards Lifesciences worth $1.86M as of Q2 2026.
  • Harbor Investment Advisory sold 1 Edwards Lifesciences share in Q2 2026, an estimated $84.
  • Edwards Lifesciences made up 0.13% of Harbor Investment Advisory's portfolio in Q2 2026, its #128 holding.
  • Harbor Investment Advisory first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • 392 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.